Loading Events

Upcoming Events

Events Search and Views Navigation

Event Views Navigation

April 2020

Proposals Due: Influenza Data Processing and Outreach

April 6
Global Biodefense Calendar

If your small business has strong experience with scientific data processing and outreach, consider sending a contract proposal to establish an Influenza Data Processing and Communication Center (iDPCC). This solicitation recompetes and renames the current influenza DPCC contract to support NIAID’s Centers of Excellence for Influenza Research and Response (CEIRR) network. Submit your proposal by April 6, 2020. If you have any questions, send them to the contracting officer listed in the solicitation no later than March 4, 2020. Learn more…

Find out more »

NASEM Webinar: The Supply Chain and COVID-19

April 8 @ 2:00 pm - 3:30 pm EDT
Virtual-Webcast

COVID-19 has had a profound impact on supply chains for many different critical products worldwide. The pandemic has created major changes in freight flows and has challenged the ability to deliver both medical supplies and food. The National Academies' Transportation Research Board (TRB) is hosting a webinar on Wednesday, April 8, 2020, from 2:00 to 3:30 PM Eastern that will explore the impacts of COVID-19 on the supply chain and logistics industries. Presenters will discuss lessons learned from past freight…

Find out more »

Deadline for NIAID BAA Proposals: Development of Radiation/Nuclear Medical Countermeasures

April 9
Global Biodefense Calendar

Research Area 001: Development of Radiation/Nuclear Medical Countermeasures (MCMs) HHS-NIH-NIAID-BAA2020-1 This research topic call for proposals is part of the 2020 NIAID Omnibus Broad Agency Announcement. It supports the development of safe and effective MCMs to mitigate and/or treat tissue injuries resulting from exposure to ionizing radiation from a radiological or nuclear incident, thereby leading to a reduction in radiation-associated morbidities and mortalities. Due Date: April 9, 2020, by 3 p.m. Eastern Time Read more about this opportunity in Funding News.

Find out more »

Deadline for NIAID BAA Proposals: Therapeutic Products for Biodefense, AMR Infections, and Emerging Infectious Diseases

April 9
Global Biodefense Calendar

HHS-NIH-NIAID-BAA2020-1 Research Area 004: Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections, and Emerging Infectious Diseases Supports development of promising new therapeutics to address infections caused by NIAID Category A, B, and C priority pathogens and select bacterial and fungal infections identified in CDC’s report Antibiotic Resistance Threats in the United States 2019 , including optimization, preclinical (investigational new drug-enabling), and clinical trials that include Phase I and Phase II studies. Due Date: April 9, 2020, by 3 p.m. Eastern Time Read more on…

Find out more »

Deadline for NIAID BAA Proposals: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases

April 9
Global Biodefense Calendar

HHS-NIH-NIAID-BAA2020-1 Research Area 003: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases Supports development of vaccines 1) to address antibiotic resistant gram-negative bacteria focusing on but not limited to Burkholderia spp., Pseudomonas aeruginosa, Francisella tularensis, Yersinia pestis, and E. coli, and 2) for emerging viruses and pandemic preparedness that includes but is not limited to alphaviruses (e.g., Eastern Equine Encephalitis) and bunyaviruses (e.g., Rift Valley Fever Virus). Due Date: April 9, 2020, by 3 p.m. Eastern Time Learn more about this opportunity…

Find out more »

Deadline for NIAID BAA Proposals: Advanced Development of Diagnostics for Biothreats and EID

April 9
Global Biodefense Calendar

HHS-NIH-NIAID-BAA2020-1 Research Area 005: Advanced Development of Diagnostics for Biothreats and Emerging Infectious Diseases Supports advancing the development of novel, rapid sample-to-answer candidate diagnostic products that will address biodefense and pandemic preparedness. Number of Awards/Total Costs: NIAID estimates that one or more awards may be issued for this Research Area for a total cost of up to $2 million for the non-severable base work across all contracts (direct and indirect costs combined). Due Date: April 9, 2020, by 3 p.m. Eastern Time…

Find out more »

POSTPONED | NO NEW DATE – BSL-4 Training: Achieving Data Quality and Integrity in Maximum Containment Laboratories

April 20 - April 24
National Institutes of Health (NIH) Bethesda, MD United States
Free

The FDA and the University of Texas Medical Branch, Galveston National Laboratory (UTMB) will host this year's annual training course on how to meet GLP requirements in BSL-4 facilities from April 20-24, 2020 at the National Institutes of Health (NIH) in Bethesda, Maryland. Scientists working to develop Medical Countermeasures (MCMs) against several high-priority biological threat agents are at high risk of aerosol-transmitted laboratory infection and life-threatening disease, as there are no vaccines or treatments for these agents. Accordingly, much of the work…

Find out more »

Quickfire Challenge Applications Due: JLABS Pediatric Influenza Innovations

April 24
Global Biodefense Calendar

Innovators within the fields of pediatric oncology, pediatric surgery and influenza are invited to submit innovative ideas for a total of up to $150,000 in grant funding; one year of residency at JLABS @ Washington, DC with the use of a bench, workstation, and access to the JLABS @ Washington, DC community; and mentorship from experts at the Johnson & Johnson Family of Companies. The submission deadline is 24 April 2020. Please visit the JLABS website for more information.

Find out more »

EZ BAA Deadline: Novel Coronavirus Rapid Diagnostic

April 30
Global Biodefense Calendar

Under this EZ BAA, the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response, will review concise abstract submissions for development funding of 2019-nCoV molecular diagnostics. The diagnostics must utilize platforms already cleared by the U.S. Food and Drug Administration, with a viable plan to meet requirements for the FDA to consider Emergency Use Authorization (EUA) within 12 weeks of an award. This area of interest will be open for…

Find out more »
+ Export Events